Replies to post #779216 on NorthWest Biotherapeutics Inc (NWBO)

[norisknorewards]

No issues with this, other than it's speculation that all pends until a PR comes from the company.

Let's avoid so much speculation and await facts from the company itself.

Thats my take. Patience is needed along with averaging down.

Anything else is noise in my opinion

[HyGro]

But Merck bought multiple biotechs and passed over DCVax-L every time. They don't need "complementary" therapies, they are all generic. Merck has seen all of DCVax-L data, is part of the UCLA SPORE trial so see all that data -- and still not buying it. They could buy NWBO with pocket change -- It's a damn $0.25 stock that is burning cash and has no capabilities to commercialize a drug.

Merck has never done a deal with an OTC biotech drug company as ANY BP. No BP trusts OTC as they have a reputation of being shady.

[Kam8]

I just want BO.  $16+ is good for me. Of course $22 is more better.